Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Verisante Technology partners with the BC Cancer Foundation to showcase Aura for skin cancer detection

Verisante Technology, a leader in cancer detection technology, announced today that the Company is partnering with the BC Cancer Foundation to showcase Verisante Aura, a device for the detection of skin cancer.

"We are very appreciative of the BC Cancer Foundation’s support for Verisante and for Aura™ and also for the Foundation’s dedication to raising funds that support innovative research directed at achieving the highest standard of care for every patient facing cancer in B.C.," said Thomas Braun, President & CEO of Verisante Technology, Inc.

Verisante has placed an Aura at the Foundation’s Provincial Office in Vancouver for display and educational purposes.

"Our unique relationship with the BC Cancer Agency allows our donors to be part of research discoveries made right here in British Columbia," said Douglas Nelson, President & CEO of the BC Cancer Foundation. "Verisante Aura™ is one of those ‘made in BC’ inventions coming out of the leading edge technology and research efforts of the BC Cancer Agency. Our Foundation is pleased to have the opportunity to demonstrate and promote this exciting technology."

The BC Cancer Foundation funds the areas of greatest priority and promise, as identified by the scientists and clinicians at the BC Cancer Agency, who look for priorities and needs that will have the most significant and timely impact on cancer care and treatment. The Foundation then partners with donors to raise the necessary funds in support of this life-saving work.

Together with its partners, the Foundation is funding and finding solutions that are having a direct impact on improving care for cancer patients in British Columbia.